Today's Daily Dose brings you news about BioCryst Pharma's ZENITH-1 study results; Cronos' partnership with Ginkgo Bioworks; Opiant's progress in Bulimia Nervosa study; OPKO Health's ongoing additional trials with RAYALDEE and TESARO's anticipated milestones.
from RTT - Biotech https://ift.tt/2NjJs6P
via IFTTT
No comments:
Post a Comment